IP Library Granted Patent US 10,272,225
Granted Patent B2
US 10,272,225 · App. 15/001,020 · Granted Apr 30, 2019

Gas delivery device and system

Inventors: Duncan Bathe (Fitchburg, WI); John Klaus (Cottage Grove, WI); David Christensen (Cambridge, WI)
Assignee: Mallinckrodt Hospital Products IP Limited
A61M16/202A61M16/0051A61M16/024A61M16/04A61M16/0666A61M16/085A61M16/0875A61M16/104A61M16/1005A61M16/12A61M16/20A61M16/204A61M16/208A61M16/0808A61M16/0833A61M16/16A61M2016/0027A61M2016/0039A61M2016/102A61M2016/1025A61M2016/1035A61M2202/0208A61M2202/0233A61M2202/0266A61M2202/0275A61M2202/0283A61M2205/18A61M2205/27A61M2205/3327A61M2205/3334A61M2205/35A61M2205/3561A61M2205/3569A61M2205/3592A61M2205/50A61M2205/502A61M2205/52A61M2205/60A61M2205/6009A61M2205/6072A61M2205/8206A61M2209/084F17C2205/013F17C2205/0161F17C2205/0308F17C2205/05F17C2205/054F17C2221/01F17C2221/011F17C2250/032F17C2270/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,272,225
App. No.
15/001,020
Granted
Apr 30, 2019
Kind
B2
Abstract

A gas delivery system including a gas delivery device, a control module and a gas delivery mechanism is described. An exemplary gas delivery device includes a valve assembly with a valve and circuit including a memory, a processor and a transceiver in communication with the memory. The memory may include gas data such as gas identification, gas expiration and gas concentration. The transceiver on the circuit of the valve assembly may send wireless optical line-of-sight signals to communicate the gas data to a control module. Exemplary gas delivery mechanisms include a ventilator and a breathing circuit. Methods of administering gas are also described.

Claims (36)

1. A gas delivery device, comprising:

a control module enclosure having mounted therein a delivery module, a control module processor and a control module memory;

wherein the control module processor is configured to control the delivery of a nitric oxide gas to the delivery module, and

a first transceiver at least partially disposed outside the control module enclosure and in electronic communication with the control module processor,

wherein, prior to delivery of the nitric oxide gas, the first transceiver is configured to receive gas data from a second transceiver disposed in a valve assembly of a gas source, the valve assembly including a valve memory that stores the gas data;

wherein the control module processor is configured to evaluate the gas data to determine that the gas source meets at least one criteria;

wherein the gas data includes at least one of gas identification, gas expiration and gas concentration; and

wherein the control module processor is configured to start flow of the nitric oxide gas to a ventilator circuit if the gas data meets the at least one criteria.

2. The gas delivery device of claim 1 wherein the control module processor is a CPU.

3. The gas delivery device of claim 1 ,

wherein the control module enclosure is affixed to a cart and the first transceiver is disposed on a cover portion; and

wherein the cart is configured to stow the gas source underneath the control module.

4. The gas delivery device of claim 3 wherein the gas source is disposed to allow communication between the first transceiver and the second transceiver via wireless optical line-of-sight signals.

5. The gas delivery device of claim 3 wherein communication between the cover portion and the control module processor is made via a cable and/or wirelessly.

6. The gas delivery device of claim 1 , further comprising:

an injector module configured to couple to a breathing circuit affiliated with a ventilator placing the injector module in fluid communication with the ventilator, and the injector module being in electrical communication with the control module processor via wired connection and/or wireless connection.

7. The gas delivery device of claim 1 wherein control module processor is configured to cause an alarm when at least one condition is identified.

8. The gas delivery device of claim 6 wherein the alarm is one of an audio alert and a visual alert presented on a display.

9. The gas delivery device of claim 1 wherein the gas data includes at least two of gas identification, gas expiration and gas concentration.

10. The gas delivery device of claim 9 wherein the gas data is gas identification and gas expiration.

11. The gas delivery device of claim 9 wherein the gas data is gas expiration and gas concentration.

12. A control module, comprising:

a control module enclosure having mounted therein a delivery module, a control module processor and a control module memory;

wherein the control module processor is configured to control delivery of nitric oxide gas;

the control module processor being electronically connected to a first transceiver at least partially disposed outside the control module enclosure and also to the control module memory;

the control module memory having stored thereon desired gas information;

wherein the first transceiver is configured to communicate with a second transceiver, disposed in a valve assembly of a gas source of nitric oxide gas, and receive via optical line-of-sight signals, prior to delivery of the nitric oxide gas, gas data associated with the gas source wherein the gas data is stored on a valve memory disposed in the valve assembly;

the gas data including at least one of gas identification, gas expiration and gas concentration;

wherein the control module processor is configured to compare the desired gas information to the gas data and determine when at least one predetermined criteria is met; and

wherein the control module processor is configured to start the inflow of nitric oxide gas to the delivery module and ventilator if the predetermined criteria is met.

13. The control module of claim 12 wherein the control module processor controls the inflow of nitric oxide by controlling a regulator connected to an outlet of the gas source.

14. The control module of claim 12 wherein an alarm alerts when at least one condition is identified.

15. The control module of claim 14 wherein the alarm is one of an audio alert and a visual alert presented on a display.

16. The control module of claim 12 wherein the gas data includes at least two of gas identification, gas expiration and gas concentration.

17. The control module of claim 12 wherein the gas data is gas identification and gas expiration.

18. The control module of claim 12 wherein the gas data is gas expiration and gas concentration.

Assignments (21)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2026
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED COMPANY
Reel/Frame 075393/0361 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 73375 FRAME 395. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 075021/0263 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 72331 FRAME 1. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 075021/0204 →
SECURITY INTEREST Recorded Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: SPECGX LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
SECURITY INTEREST Recorded Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 043601, FRAME 0025 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065610/0233 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Aug 18, 2017
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 043601/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2016
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 039818/0024 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2016
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING DAC
Reel/Frame 039817/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2016
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 039817/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2016
From: INO THERAPEUTICS LLC
To: THERAKOS, INC.
Reel/Frame 039816/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2016
From: MALLINCKRODT PHARMA IP TRADING DAC
To: MALLINCKRODT IP
Reel/Frame 039817/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2016
From: BATHE, DUNCAN P.; KLAUS, JOHN; CHRISTENSEN, DAVID
To: INO THERAPEUTICS LLC
Reel/Frame 039782/0052 →
Continuity (3)
Continuation 14065962 · Oct 29, 2013
Continuation 13509873
Related Publication 20160136377A1 · May 19, 2016